(Q73446651)

English

Efficacy and safety of docetaxel (Taxotere) in heavily pretreated advanced breast cancer patients: the French compassionate use programme experience

scientific article published on 01 October 1999

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Efficacy and safety of docetaxel (Taxotere) in heavily pretreated advanced breast cancer patients: the French compassionate use programme experience (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

expanded access

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J Bonneterre

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Spielman

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J P Guastalla

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Marty

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P Viens

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P Chollet

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

H Roché

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P Fumoleau

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

L Mauriac

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

H Bourgeois

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Namer

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J P Bergerat

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J L Misset

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

L Trandafir

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Mahjoubi

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1431-1439

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Systemic Therapy of Advanced Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Vinorelbine (navelbine) as a salvage treatment for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC. European Organization for Research and Treatment of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: report of the Clinical Screening Group of the EORTC

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Why event-free survival is better than tumor response or other measures of survival as an endpoint in cancer trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Treatment Referral Center trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors predicting for efficacy and safety of docetaxel in a compassionate-use cohort of 825 heavily pretreated advanced breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900174-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(99)00174-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673974%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73446651&oldid=1956169404"